QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lukiw, W. J. Articles by Bazan, N. G. Search for Related Content PubMed PubMed Citation Articles by Lukiw, W. J. Articles by Bazan, N. G.

---

Symposium: Dietary PUFA and the Aging Brain—Food for Thought

Docosahexaenoic Acid and the Aging Brain^1–3,

LSU Neuroscience Center of Excellence and Department of Ophthalmology, Louisiana State University Health Sciences Center, New Orleans LA 70112

The dietary essential PUFA docosahexaenoic acid [DHA; 22:6(n-3)] is a critical contributor to cell structure and function in the nervous system, and deficits in DHA abundance are associated with cognitive decline during aging and in neurodegenerative disease. Recent studies underscore the importance of DHA-derived neuroprotectin D1 (NPD1) in the homeostatic regulation of brain cell survival and repair involving neurotrophic, antiapoptotic and antiinflammatory signaling. Emerging evidence suggests that NPD1 synthesis is activated by growth factors and neurotrophins. Evolving research indicates that NPD1 has important determinant and regulatory interactions with the molecular-genetic mechanisms affecting β-amyloid precursor protein (βAPP) and amyloid beta (Aβ) peptide neurobiology. Deficits in DHA or its peroxidation appear to contribute to inflammatory signaling, apoptosis, and neuronal dysfunction in Alzheimer disease (AD), a common and progressive age-related neurological disorder unique to structures and processes of the human brain. This article briefly reviews our current understanding of the interactions of DHA and NPD1 on βAPP processing and Aβ peptide signaling and how this contributes to oxidative and pathogenic processes characteristic of aging and AD pathology.

^* To whom correspondence should be addressed. E-mail: wlukiw{at}lsuhsc.edu.

This article has been cited by other articles:

				G. Heidary, C. Lofqvist, I. S. Mantagos, D. K. Vanderveen, A. Hellstrom, and L. E. Smith Retinopathy of Prematurity: Clinical Insights from Molecular Studies NeoReviews, November 1, 2009; 10(11): e550 - e557. [Abstract] [Full Text] [PDF]

				S. I. Rapoport Arachidonic Acid and the Brain J. Nutr., December 1, 2008; 138(12): 2515 - 2520. [Abstract] [Full Text] [PDF]

				J. Whelan (n-6) and (n-3) Polyunsaturated Fatty Acids and the Aging Brain: Food for Thought J. Nutr., December 1, 2008; 138(12): 2521 - 2522. [Abstract] [Full Text] [PDF]